Yüklüyor......
The RAF Inhibitor Paradox Revisited
The success of the RAF protein kinase inhibitor vemurafenib for the treatment of BRAF-mutant metastatic melanoma has produced another poster child for the promise of personalized medicine. However, the results of a recent study also reveal unexpected pitfalls in the application of signal transductio...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2012
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3285264/ https://ncbi.nlm.nih.gov/pubmed/22340588 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccr.2012.01.017 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|